rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Alterity Therapeutics Limited - American Depositary Shares

ATHE · Nasdaq

Health CareBiotechnologyNot moving yet

ATHE stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 38.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 6
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$48K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
20 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$46KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Peter Ashley MarksDirectorbought47,620at $0.5031 Aug 2026filed 8 Sep 2026
Peter Ashley MarksDirectorbought47,620at $0.5031 Aug 2026filed 8 Sep 2026
David Allen StamlerChief Executive Officerbought47,620at $0.5031 Aug 2026filed 8 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders20+6 on the quarter
New · exited6 · 0
Reported value$2.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Twin Lakes Capital Management, LLCunchanged · filed 18 Aug 2026139,258$748K00.0%
MORGAN STANLEYadded · filed 13 Aug 202663,065$339K+4,683+8.0%
GREENLEAF TRUSTadded · filed 21 Jul 202662,000$333K+30,000+93.8%
HB Wealth Management, LLCunchanged · filed 29 Jul 202658,460$314K00.0%
CITADEL ADVISORS LLCadded · filed 14 Aug 202637,597$202K+17,520+87.3%
BNP PARIBAS FINANCIAL MARKETSadded · filed 13 Aug 202610,239$55K+3,430+50.4%
GAMMA Investing LLCadded · filed 7 Jul 20262,309$12K+453+24.4%
RHUMBLINE ADVISERSadded · filed 12 Aug 20262,009$11K+39+2.0%
Providence Capital Advisors, LLCnew · filed 11 Aug 2026200$1,074+200
Integrated Wealth Concepts LLCnew · filed 12 Aug 202673$392+73
31 Mar 2023 – 30 Jun 2026
71420Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

David Allen Stamler Company insiderChief Executive Officer · last 31 Aug 20260 · 0
Peter Ashley Marks Company insiderDirector · last 31 Aug 20261 · 0
Julian Michael Babarczy Company insiderDirector · last 15 Jun 20260 · 0
Lawrence Bernard Gozlan Company insiderDirector · last 15 Jun 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2026 · to 30 Jun 2026-97.6%

Analyst forecasts

No analyst forecasts yet.